Pharmaceutical Technology E-Alert:
Having trouble viewing this e-mail? Click here.
You are subscribed to %%list.name%% as %%emailaddr%%.
Click here to unsubscribe or edit your member profile.
  Pharmaceutical Technology Europe E-Alert
 
17 June 2011

IN THIS ISSUE
Bad ad initiative
Biosimilar development
Influenza vaccines
Nanotechnology guidance

 
FDA reviews Bad Ad programme
After looking back at the first year of its Bad Ad outreach programme, the FDA has concluded that the initiative has successfully raised awareness about misleading promotion. More...
 
Merck to develop biosimilar with Korean company
Merck and the biobusiness of Hanwha Chemical, a Korean chemical manufacturer, have formed an exclusive agreement to develop and commercialise a biosimilar of Enbrel (etanercept), which is used to treat moderate to severe plaque psoriasis, psoriatic arthritis and moderate to severe rheumatoid arthritis. More...
 
GSK expands vaccine presence in China
GlaxoSmithKline (GSK) has entered into an agreement to purchase Shenzhen Neptunus¹ stake in a previously formed joint venture between the companies involved in the development and manufacture of influenza vaccines in China, Hong Kong and Macau. More...
 
FDA issues draft guidance on nanotechnology
To provide regulatory clarity about the use of nanotechnology, the FDA has issued a draft guidance titled “Considering Whether an FDA-Regulated Product Involves the Application of Nanotechnology”, which lists points the agency will consider when determining whether a product applies nanotechnology. More...
 
Join our community on LinkedIn
Want to discuss any of this week's news stories or any other hot topics in the industry? Then why not join our group on LinkedIn? More...
 

Latest blog posts
Exploring the diabetes vaccines frontier
Lower vaccine prices for developing countries
The buck stops here
More blog posts

PTE Digital articles
The rising uptake of immediate release and ODT formulations
The influence of superdisintegrants
Tablet testing techniques
More articles

Upcoming events
From Concept to CE Marking: The Medical Device Summer School (11–15 July | UK)
Biostatistics for Non-Statisticians (11–13 July | Switzerland)
CPhI Japan (13–15 July | Japan)
More events

Product/Service Profiles
Sterilin

Superior quality pipettes for endotoxin testing
Sterilin single-use, serological pipettes are certified non-pyrogenic to a lower level than ever before (0.01EU/ml), making them ideal for pharmaceutical and medical device manufacturers to use when ensuring that their products are free from endotoxin contamination. Read more

 
Waters
placeholder

Introducing Xevo TQD from Waters - Robust. Rapid. Reliable.
Created to reduce complexity, the new Xevo TQD has been designed to deliver maximum productivity with minimum effort.
Read more

 

 


Survey
Do you think shared audits can be a tool to help manage the pharmaceutical supply chain?
Yes 71%
 
No 9%
     
Maybe 17%
     
Don’t know 3%

This week we would like to know...

Should the regulation of atypical actives (i.e., the use of an excipient as an active ingredient in a drug) be changed?

Click here to vote

Contact Us
Click here to contact editorial.

Click here to contact sales.

 
You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact
information available to third parties for marketing purposes, please contact us by emailing magazines@superfill.com or by mail
at Advanstar Communications Inc., Bridgegate Pavilion, 4A Chester Business Park, Wrexham Road, Chester, CH4 9QH, UK.